Revotek announced that it has received clearance from the National Health Commission of China to begin a clinical study in the West China Hospital, Chengdu, with its first stem cell 3D bioprinting product, REVOVAS.
New expanded indication provides patients suffering from earlier stages of heart failure access to the CardioMEMS HF System, a small implantable sensor that can flag early warning signs of worsening heart failure
Victor Dillard as VP Corporate Development and Lorna Peers as VP Finance
Phase 2a clinical proof-of-concept biomarker study for PXL065 in ALD now anticipated to start midyear
It is the first monoclonal antibody drug for use in any animal species
In India, healthcare has become one of the fastest-growing economic sectors which comprise hospitals, pharma companies, medical equipment and devices, medical tourism, health insurance, clinical trials etc
Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected
Healtherbs helps in restoring the desired energy levels for daily activity and immunity
Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease
Diabetes has the highest prevalence and comorbidities among all NCD’s in India and it is mostly found among people in the south and east India
Subscribe To Our Newsletter & Stay Updated
